Showing results (121-130 of 133) with videos related to

Sort By:
Pageof 14
Dalton Transactions (Cambridge, England : 2003)|May 10, 2011
Kojic acid derivatives as powerful chelators for iron(III) and aluminium(III)Valeria M Nurchi, Joanna I Lachowicz, Guido Crisponi, et al.
Rejuvenation Research|May 16, 2022
COVID-19 as a Paradigmatic Model of the Heterogeneous Disease Presentation in Older People: Data from the GeroCovid Observational StudyCaterina Trevisan, Francesca Remelli, Stefano Fumagalli, et al.
Journal of Inorganic Biochemistry|February 27, 2010
Iron(III) and aluminum(III) complexes with hydroxypyrone ligands aimed to design kojic acid derivatives with new perspectivesValeria Marina Nurchi, Guido Crisponi, Joanna Izabela Lachowicz, et al.
Frontiers in Plant Science|August 9, 2022
Agronomical valorization of eluates from the industrial production of microorganisms: Chemical, microbiological, and ecotoxicological assessment of a novel putative biostimulantGabriele Bellotti, Eren Taskin, Maria Chiara Guerrieri, et al.
Diagnostics (Basel, Switzerland)|February 27, 2026
Integrating Host Genetics and Clinical Setting in Machine Learning Models: Predicting COVID-19 Prognosis for Healthcare Decision-Making (The FeMiNa Study)Elisabetta D'Aversa, Bianca Antonica, Miriana Grisafi, et al.
European Journal of Internal Medicine|July 13, 2021
Prognostic interplay of kidney function with sarcopenia, anemia, disability and cognitive impairment. The GLISTEN studyLuca Soraci, Francesco Corica, Andrea Corsonello, et al.
Aging and Disease|May 12, 2025
Neurofilament-Light Chain and Glial Fibrillary Acidic Protein as Blood-Based Delirium Risk Markers: A Multicohort StudyMaria Cristina Ferrara, Lucía Lozano-Vicario, Beatrice Arosio, et al.
Journal of Medicinal Chemistry|April 5, 2023
Discovery of a Potent, Selective, and Orally Bioavailable Tool Compound for Probing the Role of Lysophosphatidic Acid Type 2 Receptor Antagonists in Fibrotic DisordersElisabetta Armani, Andrea Rizzi, Nicolò Iotti, et al.
ACS Medicinal Chemistry Letters|November 20, 2024
Design, Synthesis, and Activity of a Novel Series of Pyridazine-Based ALK5 InhibitorsDaniele Pala, Paolo Ronchi, Donatella Rescigno, et al.
ACS Medicinal Chemistry Letters|February 19, 2025
Novel Cyclohexyl Amido Acid Antagonists of Lysophosphatidic Acid Type 1 Receptor for the Treatment of Pulmonary FibrosisMarta Giuliani, Andrea Rizzi, Mafalda Pagano, et al.
Pageof 14